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AbstrACt
Objective To analyse average lifespan and quantify the 
effect of avoidable/amenable mortality on the difference 
between state-specific mortality and a low-mortality 
benchmark in Mexico during 1990–2015.
Design Retrospective cross-sectional demographic 
analysis using aggregated data.
setting Vital statistics from the Mexican civil registration 
system.
Participants Aggregated national data (from 91.2 million 
people in 1995 to 119.9 in 2015) grouped in 64 
populations (32 Mexican states (including Mexico City) by 
sex) with cause-of-death data.
Main outcome measures Cause-specific contributions to 
the gap in life expectancy with a low-mortality benchmark 
in three age groups (0–14, 15–49 and 50–84 years).
results Infants and children under the age of 15 years 
show improvements towards maximal survival in all states. 
However, adult males aged 15 to 49 years show deterioration 
after 2006 in almost every state due to increasing homicides, 
and a slow recovery thereafter. Out of 35 potential years, 
females and males live on average 34.57 (34.48 to 34.67) 
and 33.80 (33.34 to 34.27), respectively. Adults aged 50 to 
84 years show an unexpected decrease in the low mortality 
benchmark, indicating nationwide deterioration among 
older adults. Females and males in this age group show an 
average survival of 28.59 (27.43 to 29.75) and 26.52 (25.33 
to 27.73) out of 35 potential years, respectively. State gaps 
from the benchmark were mainly caused by ischaemic heart 
diseases, diabetes, cirrhosis and homicides. We find large 
health disparities between states, particularly for the adult 
population after 2005.
Conclusions Mexico has succeeded in reducing mortality 
and between-state inequalities in children. However, adults 
are becoming vulnerable as they have not been able to 
reduce the burden of violence and conditions amenable 
to health services and behaviours, such as diabetes, 
ischaemic heart diseases and cirrhosis. These trends have 
led to large health disparities between Mexican states in 
the last 25 years.
IntrODuCtIOn 
The second half of the 20th century was 
marked by sizeable improvements in 
mortality, living conditions and health in most 
Latin American countries.1 In Mexico, these 
improvements have slowed down recently 
due to opposing trends in particular causes 
of death. For instance, homicide and diabetes 
increased during the first decade of the 2000s, 
even as infectious and respiratory diseases 
continued to fall over the same period. While 
life expectancy at birth increased by 4.3 years 
for males (from 67.6 to 71.9) and 3.4 years 
for females (from 73.8 to 77.2) between 
1990 and 2000,2 between 2000 and 2010, life 
expectancy at birth entered into a period of 
stagnation for males and slowed progress for 
females.3
This period coincides with ongoing public 
health interventions, such as the Universal 
Vaccination Programme and established 
health systems (Instituto Mexicano del 
Seguro Social (IMSS), Instituto de Segu-
ridad y Servicios Sociales de los Trabajadores 
del Estado (ISSSTE)), and with the imple-
mentation of a Universal Health Coverage 
programme (Seguro Popular). The latter 
programme provides primary and secondary 
healthcare to the uninsured population and 
distributes funds to cover catastrophic health 
strengths and limitations of this study
 ► We analyse nine cause-of-death groups using the 
concept of avoidable/amenable mortality, which en-
ables us to capture recent changes in mortality in 
Mexico.
 ► We introduce a methodology to quantify the impact 
of medically amenable mortality and behaviour-re-
lated conditions on life expectancy relative to a low 
mortality benchmark.
 ► We analyse patterns in life expectancy for different 
age groups over time (1995–2015) and simultane-
ously account for changes in causes of death and 
inequality between states that have undergone ma-
jor social and public health transitions.
 ► Mortality data from Mexico are likely to present in-
accuracies in cause-of-death classification due to 
comorbidities, particularly at older ages.
 ► Our estimates of homicide mortality are likely to 
be underestimated due to inaccurate practices in 
counting and reporting and due to the large number 
of missing individuals in Mexico.
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expenditures.4 Further, since 1997 conditional cash 
transfer programmes were introduced to supply incen-
tives for poor families to invest in education, health and 
nutrition.5 Some evidence suggests that Mexico experi-
enced substantial decreases in infant and child mortality, 
and in the prevalence of acute malnutrition between 1980 
and 2000 thanks in part to these interventions.6 Similarly, 
by 2012 Seguro Popular had provided health insurance 
coverage to an additional 52 million people in Mexico 
(or 44.4% of the population), leading to increased access 
to public healthcare and protection from the financial 
consequences of disease.7
Conditional cash transfers have focused on the poorest 
states, and Seguro Popular was introduced at different times 
in different states across the country. Although these actions 
underscore broad progress in public health interventions, 
they mask disparities between Mexican states and epidemio-
logical patterns that differ between age groups. For instance, 
Mexico faces a rapid ageing process in which an interaction 
between infectious diseases and non-communicable condi-
tions can be anticipated in the adult population.i8 There-
fore, it is necessary to assess the varied impacts that these 
interventions may have had on mortality in Mexican states 
at different ages.9
One approach to approximate the impact of health-
care and other interventions on survival, and to reveal 
potential areas of improvement is by operationalising the 
concept of avoidable or amenable mortality (hereafter 
abbreviated AM).10 11 This categorisation of mortality 
aims to measure the quality of health service systems by 
selecting certain causes of death that should not occur in 
the presence of effective and timely healthcare. There-
fore, improvements in AM are expected over time, as has 
been observed in several countries. For example, among 
19 industrialised countries, including 14 countries from 
Western Europe, USA, Canada, Australia, New Zealand 
and Japan, a reduction in AM rates was observed over the 
past 20 years.10 Avoidable mortality rates fell, on average, 
by 17% for males and 14% for females in these coun-
tries between 1997 and 2003. The USA lagged behind 
the other countries in this group, while Japan, France 
and Australia were the top performers. Despite mortality 
reductions from cancers and circulatory diseases for both 
sexes, disparities between countries persist, with the USA 
showing the smallest reductions (around 5%) for both 
sexes.10
In Mexico, the components of avoidable mortality have 
undergone opposing trends since the late 1990s. Mortality 
from infectious diseases and nutrition-related conditions 
decreased between 2000 and 2004,12 while deaths related 
to diabetes and ischaemic heart diseases (IHD) increased 
in the first decade of the 2000s.13 Importantly, increases 
in the latter causes of death were concentrated in the 
poorest states of the country.13
i The percentage of the population aged 65 or older is projected to go 
from 6.0% in 2015 to 10.2% in 2030 (Reference: CONAPO).
The objective of this research is twofold. First, we analyse 
trends in average lifespan for all 32 Mexican states, by sex, 
and over the full period from 1990 to 2015. This extends 
previous studies that focused on the 21st century.3 13–16 
Our study period covers several public health interven-
tions and captures several major trends in state and cause-
of-death variation. Second, we further segment AM into 
health intervention-related and behaviour-related AM 
causes that best characterise the epidemiological patterns 
of Mexico.14 This lets us quantify the effect of the compo-
nents of AM on the difference between state mortality 
levels and an easy-to-understand low-mortality bench-
mark calculated for large age groups (ie, 0–14, 15–49 and 
50–84 years). This benchmark concept has been previ-
ously used in mortality studies.17–19 Deviations from the 
low-mortality benchmark indicate a strong potential for 
improvement.
We hypothesise age-dependent variations in mortality 
outcomes. In particular, since public health interventions 
are mainly focused on infant and child health, we expect 
convergence between states and improvement in survival 
for infants and children aged 0 to 15 years. For instance, 
the vaccination programme and Seguro Popular aim to 
cover all children, and recent evidence suggests a decrease 
in mortality below the age of 15 years due to a decline in 
infectious and respiratory diseases.20 On the contrary, we 
expect little improvement in survival for the young adult 
population (ages 15 to 35 years) due to the sudden and 
egregious rise in homicide mortality.21 We foresee health 
deterioration among older adults due to documented 
increases in diabetes mortality.20 Although every state 
has the commitment to provide universal coverage and 
equitable access to healthcare, we anticipate disparities 
in mortality improvements between states due to hetero-
geneous epidemiological transitions among states,16 and 
differences in the implementation and delivery of health-
care programmes.22
Data sources and methods
Our analyses are based on publicly available anonymised 
datasets. We used 100% sample death register microdata 
files produced by the Mexican Statistical Office (INEGI) 
for years 1990 to 2015.23 We aggregated individual deaths 
from these annual files by causes of death, single year 
of age, sex and state of residence at the time of death. 
Population estimates from 1990 to 2015 were produced 
by the Mexican Population Council (CONAPO).24 These 
population estimates adjust for age misstatement, under-
counting, and interstate and international migration. 
Death counts and estimates of the population exposed to 
risk were used to calculate age and cause specific death 
rates by sex for each state from 1990 to 2015.
Classification of causes of death
To classify deaths, we use the AM concept.10 11 We group 
causes of death into nine categories based on recent 
classification adapted to the case of Mexico.14 The first 
category refers to those conditions that are susceptible 
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to medical intervention, such as infectious and respira-
tory diseases, some cancers and circulatory conditions, 
and birth conditions, among others. We label this cate-
gory as ‘Causes amenable to medical service’. We separate 
diabetes, IHD, lung cancer and cirrhosis as subcategories 
of AM because these causes are susceptible to both health 
behaviour and medical service, and because the first two 
represent major causes of death among Mexican adults.16 
We also separate homicide, suicide and road traffic acci-
dents because they have emerged as leading causes of 
death among young people, and the first one recently 
had a sizeable impact on life expectancy in Mexico.14 We 
grouped remaining causes into a single category labelled 
‘Other causes’.
Death data were originally classified according to the 
International Classification of Diseases (ICD), revision 9  for 
years 1990 to 1997 and revision 10 for 1998 to 2015 (see 
online supplementary table 1 for details on ICD codes for 
each category). To check the validity of these cause-of-death 
codes in Mexico, we performed a sensitivity analysis and did 
not find major ruptures in mortality trends by AM classifica-
tion (online supplementary figure 1).
Comorbidity in the old age population has increased 
in Mexico.25 As a result, inaccuracies may arise in cause 
of death registration due to problems associated with 
medical diagnosis, and selection and coding of the 
leading cause of death. Although analyses of older ages 
should consider multiple causes of death to better repre-
sent old age mortality, we focus on the primary cause of 
death. We truncate our analysis at age 85 to avoid misin-
terpreting results related to inaccurate cause-of-death 
coding practices.
Age groups
We calculate life expectancy in three large age groups to 
capture mortality differences over the life course. Life expec-
tancy in each age group refers to the average years of life 
lived between two ages conditional on survival to the lower 
age bound. This measure is also known in demographic 
analysis as temporary life expectancy.26 The first age group 
contains infants and children aged 0–14 years. This group 
is likely to represent improvements in causes amenable to 
medical service (eg, infectious diseases and conditions of 
the perinatal period).3 The second group, aged 15–49 years, 
is used to capture the effect of homicide mortality and 
external causes historically related to the young-adult 
mortality hump, as well as maternal mortality for women.27 
This age group had an important impact on changes in state 
life expectancy in the first decade of the 2000s.14 The third 
group covers older adults aged 50–84 years. Older adults are 
likely to represent a vulnerable group due to increases in 
non-communicable diseases and injury-related mortality in 
recent years.16 28
Low mortality benchmark
Our low mortality benchmark is calculated on the basis of 
the lowest observed mortality rates over all states by age, 
year, cause and sex. The resulting minimum mortality rate 
schedule has a unique age profile, and it determines our 
benchmark temporary life expectancy, which we calculate 
for our three age groups. This benchmark is a practical 
reference because it is based neither on a projection of 
improvements into the future nor on an arbitrary and 
likely dissimilar population. It can be treated as the best 
presently achievable mortality assuming perfect diffu-
sion of the best available practices and technologies in 
Mexico.19
MethODs
Cause-specific death rates underlie all indices reported 
in this work. To mitigate the impact of random varia-
tions over time and to correct for age heaping, we adjust 
these rates in two steps. First, we smooth cause-specific 
rates over age and time for each state and sex separately 
using a 2-d p-spline.29 Second, we rescale the smoothed 
cause-specific death rates to sum to the raw all-cause 
death rates for each sex and state. Period life tables up 
to age 84 for males and females from 1990 to 2015 and 
their benchmarks were calculated following standard 
demographic methods (for life table construction, see 
Chapter 2 of reference 31).30 31 We calculated temporary 
life expectancies26(see online supplementary file 1 for a 
technical overview and 95% CIs) and estimated cause-spe-
cific contributions to the difference between each state 
and the low mortality benchmark using standard decom-
position techniques.32 The decomposition method used 
in this analysis is based on a model of demographic 
functions that change gradually over time.32 It is a step-
wise-based demographic method and has been success-
fully used to decompose age-specific and cause-specific 
effects on life expectancy.33 We provide a short descrip-
tion in the online supplementary material and the results 
are fully reproducible from the R-code provided in the 
data sharing statement. Finally, to measure the level of 
disparity between states over time, we calculated the coef-
ficient of variation of the gap between temporary life 
expectancy and the low mortality benchmark in each 
age group. This indicator is comparable over time and 
over age groups of different widths. We also performed 
two-way analysis of variance (ANOVA) and post hoc 
tests to analyse disparities in temporary life expectancy 
between Mexican states and age groups.
Patient involvement
No patients were involved in setting the research question, 
outcome measures or design of the study. No patients were 
asked to advise on the interpretation of the results and there 
are no plans on disseminating the results of this research to 
study participants or the relevant patient community.
resuLts
trends in life expectancy for Mexican states by age groups
Figure 1 presents temporary life expectancy by state for 
infants and children (ages 0–14), young adults (15–49) 
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and older adults (50–84) over the period 1990–2015. 
Grey lines refer to each of the 32 states, black lines repre-
sent the state average and the blue lines represent the low 
mortality benchmark. The black line at the top of each 
panel indicates the maximum liveable years in each age 
group: 15 for the youngest group, and 35 for young and 
older adults conditional on surviving to ages 15 and 50, 
respectively. Any gap between a state line and the blue 
line represents potential life expectancy gains if mortality 
were to drop to the low mortality benchmark.
All states show improvements in the youngest age 
group since 1990, approaching the low mortality bench-
mark, which itself is very close to maximum survival below 
age 15. This was observed even in the southern states 
such as Puebla, Chiapas and Tabasco which have lagged 
in reducing mortality in this age group throughout the 
entire period.
Male life expectancy between ages 15 and 49 showed a 
sudden drop after 2005 in almost every state in Mexico. In 
2005, young males in this age group had a temporary life 
expectancy of 33.9 years (95% CI 33.5 to 34.2) averaged 
over states. By 2010, the number of states below this level 
had increased from 14 to 23. Chihuahua, Sinaloa and 
Durango, in the northern region, experienced a substan-
tial mortality shock in 2010 in this age group and conse-
quently recorded the largest gap from the low mortality 
benchmark. By 2015, the state average (33.8 years, 
95% CI 33.3 to 34.3) had almost recovered to its 2005 
level. Trends for females are closer to the low mortality 
benchmark.
Among older adults, life expectancy between ages 50 
and 84 shows stagnation and deterioration over the entire 
period of observation. Even the low mortality benchmark 
exhibits a gradual downward trend, pointing to a gener-
alised mortality increase. The state average female life 
expectancy declined from 28.8 years (95% CI 27.4 to 30.2) 
in 1990 to 28.3 years (95% CI 27.4 to 29.2) in 2010. By 
2015, this average only managed to recover to 28.6 years 
(95% CI 27.4 to 29.8). Among males, the average over 
states decreased from 26.7 years (95% CI 24.7 to 28.8) 
in 1990 to 26.3 years (95% CI 24.9 to 27.6) in 2010, and 
26.5 years (95% CI 25.3 to 27.7) in 2015. Furthermore, 
we fitted three linear models by sex and for both sexes, 
and the slope coefficient was significant in all of them at 
the level of p<0.005. These results suggest that the decline 
observed was significant. As with young adult males, some 
states experienced deterioration after 2005, with a minor 
recovery since 2010.
health disparities between states and age groups
Figures 2–5 show results only for males because they 
exhibit the largest departures from the low mortality 
benchmark and higher inequality. Results for females are 
shown in the online supplementary file 1.
Figure 2 shows trends in inequalities between states in 
Mexico for males in our three age groups, as measured 
by the coefficient of variation (results for females are 
reported in online supplementary figure 2). This indicator 
measures the between-state variation in the state-specific 
benchmark within each of the three age groups. Larger 
Figure 1 State-specific life expectancy trends (grey), average (black) and low mortality benchmark (blue) for three age groups, 
the youngest (0–14 years), young adults (14–49 years) and older adults (50–84 years) by sex for the period 1990–2015. Source: 
calculations based on INEGI and CONAPO files. CONAPO, Mexican Population Council; INEGI, Mexican Statistical Office. 
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values are related to higher disparities between states. 
Trends show mixed patterns of convergence with tempo-
rary divergence around 2010, and with females in all cases 
showing less between-state inequality than males over the 
entire period studied.
There are important differences in inequality levels and 
trends between age groups. Since 1990, state inequality 
in life expectancy in the youngest age group has been 
decreasing. Among females, young adults show even 
lower between-state disparity than infants and children. 
However, for males in the young adult age group, there 
was a crossover in the early 2000s, with the coefficient of 
variation increasing after 2005. The highest values are 
observed in the period 2009–2011. By 2015, state inequal-
ities among young adults had decreased substantially, but 
remained higher than that of the youngest age group. 
Older adults show substantially higher inequality than 
the other age groups over the entire period studied, but 
also show steady convergence between states. From 2013, 
both males and females show a potential rise in dispari-
ties between states, but we caution that this rise could be 
random variation as it only appears for 2 years (online 
supplementary figure 2).
To illustrate discordance between age groups within 
each state, figure 3 shows the state ranking of tempo-
rary life expectancy for the years 2010–2015 for males in 
each age group (see online supplementary figure 3 for 
females’ results). States at the top show the highest values 
in temporary life expectancy, while states in the bottom 
refer to the lowest expectancies. We chose to highlight 
those states with the most discordant age rankings. Green 
and purple lines refer to selected states that show drastic 
changes in the ranking between different age groups. 
For example, Sinaloa, in the northern part of Mexico, 
holds the record life expectancy below age 15; however, 
young adults (15–49 years) show one of the lowest expec-
tancies, while older adults are in the sixth position out 
of 32. Similar trajectories are shown with green lines for 
Nayarit and Michoacán in the central region, Zacatecas 
in the North, as well as Morelos and Guerrero from the 
southern region. Conversely, the pattern of age discor-
dance in Hidalgo, Querétaro and Mexico City from the 
central region, and Yucatán and Puebla in the South 
(purple lines) is summarised by changing from a low rank 
in the youngest age group to a high rank in young adults, 
followed by low rank in older adults.
We performed a two-way ANOVA on temporary life 
expectancy by state and age groups controlling for year. 
There was a statistically significant interaction between 
the effects of states and age groups (F=12.25, p<0.001) 
indicating, as shown in figure 3, that part of the existing 
variation in the country is due to variability within each 
state. There were also significant differences in tempo-
rary life expectancy between age groups (p<0.001) and 
states (p<0.001) reflecting between-state variability, as 
shown in figure 2.
Cause decomposition analysis
In figures 4 and 5, the Mexican states in each region 
are arranged according to the largest gap with the low 
Figure 2 Inequality in male life expectancy between states for the youngest (0–14 years), young adults (15–49 years) and 
older adults (50–84 years), 1990–2015. Source: calculations based on INEGI and CONAPO files. CONAPO, Mexican Population 
Council; INEGI, Mexican Statistical Office. 
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mortality benchmark among older adult males in 2015. 
Figure 4 shows how causes amenable to medical service, 
diabetes, IHD, lung cancer, cirrhosis, homicide and road 
traffic accidents contributed to the gap between each 
state and the low mortality benchmark from 1990 to 2015 
for older males (ages 50–84). These are the causes of 
death that contributed the most to holding states back 
from achieving the low mortality benchmark. Light-yellow 
colours indicate negligible contributions, which means 
that are very close to the low mortality benchmark within 
each category. Darker red hues indicate larger contribu-
tions to the gap. If a state is improving during the period, 
it shows a transition from red to light yellow.
Medically amenable causes of death show gradual 
improvements in most states from 1990 to 2015, bringing 
them closer to the benchmark in this category. However, 
large disparities persist between states and a strong 
potential for improvements remain. For example, Baja 
California, Sonora, Chihuahua and Coahuila from the 
northern region show substantial contributions to the 
gap. Diabetes mortality has increasingly contributed to 
widening the benchmark gap in several states, including 
Coahuila and Tamaulipas in the North, Mexico City, 
Guanajuato, Mexico state, and Tlaxcala in the central 
region, and Puebla, Veracruz and Tabasco in the South. 
Similarly, IHD significantly affects the northern part of 
the country, while cirrhosis is mostly concentrated in the 
South. Lung cancer and road traffic accidents have lower 
contributions to the benchmark gap, but these remain 
important causes of death. Homicides increased the 
gap in this age group in some states after 2005, such as 
Chihuahua, Durango and Sinaloa in the North, Colima, 
Figure 3 Discordant age rankings for average male life expectancy 2010–2015 for the youngest (0–14 years), young adults 
(14–49 years) and older adults (50–84 years). Source: calculations based on INEGI and CONAPO files. CONAPO, Mexican 
Population Council; INEGI, Mexican Statistical Office. 
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Michoacán and Nayarit in the central region, and Guer-
rero in the South.
Females show similar regional patterns to males, 
although of lower magnitudes. For males, causes amenable 
to medical service, diabetes and IHD contributed the 
largest share to the gap with the low mortality benchmark 
among older adult females. In the youngest age group, 
improvements in life expectancy and in reducing the gap 
with the low mortality benchmark were mainly driven by 
causes amenable to medical service among both females 
and males. Finally, homicide mortality and road traffic 
accidents are the main drivers of the gap with the bench-
mark among young male adults (ages 15–49). Impor-
tantly, homicides contributed more than 2.5 years to the 
gap with the low mortality benchmark in 2010 in the 
northern state of Chihuahua, and several states from the 
North and South of Mexico showed substantial impacts 
from homicide after 2005. Results for all age groups are 
shown in online supplementary figures 4–9.
Potential gains and causes of death in 2015
Figure 5 breaks down the state-specific low mortality 
benchmark gap for males aged 50–84 years into poten-
tial gains and their cause of death composition. The left 
panel shows the potential gains for older adults if the 
low mortality benchmark were achieved for each state in 
2015. The right panel shows the proportion of potential 
gains due to specific causes of death in the same year.
Every state in Mexico could increase survival by at 
least 1 year on average in older adult ages if they were to 
achieve the low mortality benchmark. However, for 17 of 
them the gap with the benchmark is higher than 2 years, 
and for 3 states in the northern region it is greater than 
3 years. For females, except for Sinaloa and Nayarit, all 
states show the potential to gain over an additional year 
of life between ages 50 and 84.
More than half of these potential gains in life expec-
tancy between ages 50 and 84 are due to medically 
amenable causes, diabetes, IHD and cirrhosis in every 
state in Mexico (right panel). This is true also for females. 
Although older males show lower impact of homicide 
mortality on potential gains compared with young adult 
males (15–49 years), its effect is present in almost every 
state, particularly in Guerrero, Morelos in the South, 
Nayarit and Colima in the central region and Sinaloa 
in the North. Results for all the age groups for the years 
2005, 2010 and 2015 are shown in the online supplemen-
tary figures 10–18.
DIsCussIOn
In Mexico since 1990, life expectancy in three large age 
groups has followed discordant patterns of rise, stag-
nation and deterioration. These patterns were driven 
mainly by causes of death that are amenable to medical 
service (such as infectious and respiratory diseases) and 
health behaviours (such as homicides, suicide, diabetes, 
IHD and cirrhosis). Patterns in these two large cause-of-
death categories led to high levels of health inequality in 
the country.
Life expectancy below age 15 converged towards the 
low mortality benchmark and maximum survival in 
all 32 Mexican states. These results underscore public 
health interventions aimed at infants and children. This 
Figure 4 Cause-specific contributions to the gap between states and low mortality benchmark for older male adults (50–
84 years), 1990–2015. Source: calculations based on INEGI and CONAPO files. CONAPO, Mexican Population Council; INEGI, 
Mexican Statistical Office. 
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is supported by evidence that vaccination coverage has 
been achieved for the entire young population and that 
health insurance coverage has improved due to vacci-
nation programmes and the implementation of Seguro 
Popular along with improvements in previously existing 
health systems, respectively.9 Causes amenable to medical 
service are at the heart of such improvements, consisting 
of decreases in infectious and respiratory diseases asso-
ciated with public health interventions targeting chil-
dren.6 For example, Puebla and Tlaxcala (in the South 
and central regions, respectively) were the states with the 
lowest life expectancy below age 15 in 1990, but they have 
since improved by more than half a year. Moreover, the 
average over states improved from 14.5 in 1990 to 14.8 in 
2015, with no state below 14.7. Because of continuous and 
nationwide convergence towards the low mortality bench-
mark, inequalities between states in life expectancy below 
age 15 have been reduced.
Opposing the optimistic trend of infants and children, 
increases in homicide mortality reversed gains in male life 
expectancy, particularly between ages 15 and 49 years. 
These results are consistent with previous studies quanti-
fying the effect of homicide mortality on the stagnation 
of national life expectancy at birth in the first decade of 
the 21st century,3 and with the reversal experienced in 
life expectancy in most states between 2005 and 2010.14 
Our results extend such findings by adding 5 years of 
data and segmenting by three age groups capturing 
stages of the life course.34 We found that after 10 years 
of the unexpected rise in homicide mortality, most states 
have experienced a slow and partial recovery since 2010. 
However, the impact of homicide is still higher than 
the levels observed pre-2005. Between 2010 and 2015, 
homicides accounted for most of the gap between states 
and the low mortality benchmark in ages 15–49. For 
this age group, the states that show the greatest bench-
mark gap for homicide in 2015 are Guerrero in the 
South, and Sinaloa and Chihuahua in the North, which 
could gain 1 year, and half a year (each), respectively, 
if homicides were reduced to the level of the southern 
state of Yucatán, which in this case makes up 100% of 
the benchmark. Moreover, health inequalities in life 
expectancy between states followed the rise in homicides 
after 2005 (figure 2), and the considerable discordance 
between age groups (figure 3) was likely due in great part 
to homicide mortality in ages 15–49. It is unclear how 
Figure 5 State-specific gap with the low mortality benchmark and its cause-of-death composition for older male adults 
(50–84 years) in 2015. Source: calculations based on INEGI and CONAPO files. CONAPO, Mexican Population Council; INEGI, 
Mexican Statistical Office. 
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these levels of state life expectancy will change with the 
new reports which highlight a 3-year increase in homi-
cide in Mexico.23,ii Further, the exposure that people 
have had to violence has triggered mental health prob-
lems, for example, a widespread heightened perception 
of vulnerability.15 At the same time, suicide is strongly 
linked to mental disorders.35 Thus, if the Mexican health 
system does not have proper interventions to handle the 
mental health needs of the population, an increase in 
suicides might be observed in the future.
The population aged 50–84 years shows the largest low 
mortality benchmark gap in both females and males. Out 
of 35 liveable years in this age group, females lived on 
average 28.6 years and males 26.5 in 2015 without any 
clear improvement in the 26 years since 1990. Even the 
low mortality benchmark itself shows a downward trend 
for males and females (figure 1). Moreover, this age 
group exhibits the highest inequality between states in 
the last 26 years. Our results show that causes of death 
holding states back from the low mortality benchmark 
vary between regions. Causes amenable to medical 
service showed gradual improvements in almost every 
state since 1990. However, in some states of the northern 
region such as Baja California, Sonora and Chihuahua, 
these causes of death still show large room for improve-
ments among older adults. Diabetes, IHD and cirrhosis 
account for most of the gap with the benchmark 
mortality, and these display large regional differences. 
For example, IHD is mostly concentrated in the North 
(figure 4), while cirrhosis and diabetes show a stronger 
impact in the central and southern regions. These results 
are supported by previous evidence documenting an 
increase in adult mortality rates from chronic kidney 
disease, diabetes and cirrhosis since 2000.16 Lung cancer 
and homicides had a lower impact on life expectancy for 
this age group, and both are higher in the northern part 
of the country.
strengths and limitations of the study
Our analytical approach enables us to measure the 
years of life expectancy that could be gained in Mexican 
states by improving medically amenable mortality and 
behaviour-related mortality to the lowest levels presently 
observed in Mexico. This concept allows us to analyse 
patterns in life expectancy for different age groups over 
time and simultaneously account for changes in causes of 
death and inequality between states that have undergone 
major social and public health transitions.
The limitations of our study should be mentioned. First, 
mortality data from Mexico are likely to present inaccura-
cies in cause-of-death classification due to comorbidities, 
particularly at older ages.36 To mitigate this, we focus on 
ages below 85 and broad cause-of-death groups. In addi-
tion, road traffic accidents and homicides may happen 
ii https://www.businessinsider.com.au/homicides-hit-new-high-mexico-
alongside-increase-in-robberies-2017–11?r=US&IR=T.
not in the place of residence but in another state, which 
might cause differences in state-specific mortality. More-
over, our estimates regarding homicide mortality are 
likely to be underestimated due to inaccurate coding 
and reporting practices and due to the large number of 
missing individuals in Mexico.37 38 Similarly, in 1997, a 
change in diagnosis criterion for diabetes took place, and 
this could have an impact on trends of mortality caused 
by diabetes in years adjacent to 1997.39 In addition, 
under-reported deaths and ill-defined causes of death 
could potentially bias our results. Mexico is considered 
to have high-quality data according to the Pan American 
Health Organization’s criteria. Under-reported deaths 
are estimated to be around 0.8%,40 41 while ill-defined 
causes of death fell from 2.1% of all deaths around 2000 
to 1.7% more recently.40 We expect our main findings to 
be robust given the small percentages of ill-defined and 
under-reported deaths. Finally, small population sizes 
could bias our results. As a robustness check, we calcu-
lated CIs (95%) for all our estimates of temporary life 
expectancy, including the benchmark (see online supple-
mentary material) and did not find major differences 
with our main results.
Avoidable mortality should be understood as an indi-
cator of potential weaknesses with respect to healthcare 
and some public health policies and not as a definitive 
assessment.10 The number of deaths that should be 
considered avoidable is not clear.42 For instance, some 
researchers consider only half of heart disease mortality 
to be avoidable.43 44 There is no direct information to 
precisely measure percentages of avoidable mortality 
within cause groups in Mexico. Nonetheless, the differ-
ence between a given mortality schedule and the best 
mortality schedule of the same year can be conceived of 
as a minimal definition of avoidable mortality. The bench-
mark mortality schedule sets a lower bound to how much 
mortality could have been avoided. Certainly, even the 
best mortality schedule will contain elements of mortality 
that most would consider avoidable. To the extent that 
the components of the benchmark schedule were indeed 
attained somewhere in Mexico, one can view any excess 
mortality with respect to the benchmark schedule as pres-
ently avoidable. We believe this perspective improves on 
the AM concept by giving a directly measurable standard 
against which to estimate avoidable deaths.
Implications of findings
Beyond the mortality implications of the rise in homi-
cide, violence has had a toll on perceived vulnerability 
in the country.15 The recent increase in homicides in 
some states could trigger an increase in the perception 
of vulnerability, which would result in a higher average 
lifetime experience of fear in specific states. Although 
we are not able to link the trends in mortality among 
young adults in Mexico with specific public policies, 
some evidence suggests that the propagation of homi-
cide mortality is not only a result of the war between drug 
cartels but also because of the implementation of specific 
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policies aimed to mitigate drug cartel operations after 
2006.45 There is no simple way to lessen the impact of 
homicide mortality, but it is clear that the government 
has not been able to reduce its burden to levels observed 
before 2005. Furthermore, state homicide rates may 
underestimate the effect of violence in particular local-
ities. For example, Guerrero in the South has two of the 
most dangerous cities in the world,iii but no information 
is available on the heterogeneity in homicide mortality 
for the rest of the state.
The fact that in 2015 older adults in Mexico could add 
more than 1 year of life in every state for males, and in 30 
states for females by achieving the benchmark mortality 
levels, underscores vulnerability in these ages. Public 
health interventions targeting specific causes of death for 
this age group according to the epidemiological profile 
of each state would not only increase state life expectancy 
but it would also forge a path towards more equality 
between states in health outcomes. More than half of the 
potential gains in life expectancy between ages 50 and 
84 are due to avoidable mortality, and to a large extent 
mortality related to health behaviours and medically 
amenable causes. For instance, obesity and overweight, 
risk factors for diabetes and IHD, have dramatically 
increased since the 1990s in low/middle-income coun-
tries because of the consumption of cheap, energy-dense 
food and reduced physical activity.46 Mexico, along with 
the USA, has the highest prevalence of overweight and 
obesity among all OECD (Organisation for Economic 
Co-operation and Development) countries20 and one 
of the highest in Latin America, along with Chile, El 
Salvador, Honduras and Paraguay.47 However, obesity 
prevalence is not homogeneous across Mexico. The 
highest rates of obesity are concentrated in the northern 
and central regions20 and in urban areas of the country,48 
which roughly matches our regional pattern of IHD and 
diabetes mortality.
COnCLusIOn
Mexico stands today at an advanced stage of the epide-
miological transition.16 However, this transition was 
achieved rapidly and the health system is ill-prepared for 
the burden of non-communicable diseases.49 The cardio-
vascular mortality reductions that brought the developed 
world into advanced levels of life expectancy are still in 
progress in Mexico. Nevertheless, no single solution is 
available to reduce behavioural mortality in this country 
since, as we show, great heterogeneity in mortality levels 
exist between states.
Signs of a fragile situation in the health and mortality of 
the oldest age group are highlighted by the decline in the 
low mortality benchmark used in our analysis. Population 
ageing could scale up this situation if timely preventive 
iii http://www.economist.com/blogs/graphicdetail/2017/03/
daily-chart-23
measures are not put in place. Furthermore, a resur-
gence of violent deaths14 15 21 has created a new burden 
in Mexican society.
As is the case in many low/middle-income countries, 
Mexico will have to face these new challenges with a broad 
strategy. This should include a continuous and adaptable 
health system ready for the current and future health 
adversities at the physical, mental and societal levels. Many 
other institutions will also have to coevolve including 
importantly the development of an education system that 
embraces and encourages physical and healthy activi-
ties to diminish risk factors that contribute to the high 
prevalence of obesity and cirrhosis in Mexico. Finally, 
the burden of violence in recent years demonstrates the 
failure of current policies trying to mitigate violence in 
the country. New strategies that replace current ones are 
needed and embracing evidence-based policies (eg, drug 
policies) could be a new venue to eradicate the conse-
quences of violence on the Mexican population.
Acknowledgements JMA acknowledges the support from the Max Planck Society 
(LIFEINEQ group), the European Doctoral School of Demography and his current 
institution. All authors are grateful with the University Library of SDU for the Open 
Access fee.
Contributors JMA and TR contributed to data collection, study design, data 
analysis and interpretation of the results, and wrote the first draft of the paper. VC-R 
contributed to the study design, interpretation of the results, drafting of the paper 
and finalising the paper. JMA is the guarantor of this study.
Funding This study was supported by Syddansk Universitet, Max-Planck-
Gesellschaft (ERC grant no: 716323) and European Doctoral School of Demography.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data used are publicly available in references 22 and 
23. All the study is fully replicable at https:// github. com/ jmaburto/ DecompMex.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. World Health Organization. The world health report 2000: 
health systems: improving performance. Geneva: World Health 
Organization, 2000.
 2. Mexican Society of Demography. Conciliación demográfica de 
México y entidades federativas 1990–2010. Mexico City: SOMEDE-
CONAPO, 2010.
 3. Canudas-Romo V, García-Guerrero VM, Echarri-Cánovas CJ. The 
stagnation of the Mexican male life expectancy in the first decade of 
the 21st century: the impact of homicides and diabetes mellitus. J 
Epidemiol Community Health 2015;69:28–34.
 4. Knaul FM, Frenk J. Health insurance in Mexico: achieving universal 
coverage through structural reform. Health Aff 2005;24:1467–76.
 5. Neufeld LM. The oportunidades program and child growth: Mexico 
perspectives: handbook of growth and growth monitoring in health 
and disease: Springer, 2012:1659–71.
 6. Sepúlveda J, Bustreo F, Tapia R, et al. Improvement of child survival 
in Mexico: the diagonal approach. Lancet 2006;368:2017–27.
 7. Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest 
for universal health coverage: achieving social protection for all in 
Mexico. Lancet 2012;380:1259–79.
 8. Bygbjerg IC. Double burden of noncommunicable and infectious 
diseases in developing countries. Science 2012;337:1499–501.
 o
n
 2 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022350 on 1 August 2018. Downloaded from 
11Aburto JM, et al. BMJ Open 2018;8:e022350. doi:10.1136/bmjopen-2018-022350
Open access
 9. Urquieta-Salomón JE, Villarreal HJ. Evolution of health coverage in 
Mexico: evidence of progress and challenges in the Mexican health 
system. Health Policy Plan 2016;31:28–36.
 10. Nolte E, McKee CM. Measuring the health of nations: updating an 
earlier analysis. Health Aff 2008;27:58–71.
 11. Nolte E, McKee M. Measuring the health of nations: analysis of 
mortality amenable to health care. BMJ 2003;327:1129.
 12. Franco-Marina F, Lozano R, Villa B, et al. La mortalidad en México, 
2000-2004. Muertes evitables: magnitud, distribución y tendencias: 
Dirección General de Información en Salud, Secretaría de Salud 
México, 2006.
 13. Dávila-Cervantes CA, Agudelo-Botero M. Mortalidad evitable en 
México y su contribución a los años de vida perdidos: Análisis por 
grado de marginación estatal, 2001-2010. Papeles de población 
2014;20:267–86.
 14. Aburto JM, Beltrán-Sánchez H, García-Guerrero VM, et al. Homicides 
in mexico reversed life expectancy gains for men and slowed them 
for women, 2000-10. Health Aff 2016;35:88–95.
 15. Canudas-Romo V, Aburto JM, García-Guerrero VM, et al. Mexico's 
epidemic of violence and its public health significance on average 
length of life. J Epidemiol Community Health 2017;71:188–93.
 16. Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, et al. Dissonant 
health transition in the states of Mexico, 1990-2013: a systematic 
analysis for the global burden of disease study 2013. Lancet 
2016;388:2386–402.
 17. Whelpton PK, Eldridge HT, Seigel JS. Forecasts of the population of 
the United States, 1945-1975: US Govt. Print. Off, 1948.
 18. Wunsch G. A minimum life-table for Europe. Europ Demogr Inf Bull 
1975;5:2–10.
 19. Vallin J, Meslé F. Minimum mortality: a predictor of future progress? 
Population 2008;63:557–90.
 20. González-Pier E, Barraza-Lloréns M, Beyeler N, et al. Mexico's path 
towards the sustainable development goal for health: an assessment 
of the feasibility of reducing premature mortality by 40% by 2030. 
Lancet Glob Health 2016;4:e714–e725.
 21. Gamlin J. Violence and homicide in Mexico: a global health issue. 
Lancet 2015;385:605–6.
 22. Frenk J. Bridging the divide: global lessons from evidence-based 
health policy in Mexico. Lancet 2006;368:954–61.
 23. INEGI. Estadísticas vitales Mortalidad: National Institute of Statistics 
Mexico, 2017.
 24. CONAPO. Mexican population council: population estimates 2017. 
2017 https:// datos. gob. mx/ busca/ dataset/ activity/ proyecciones- de- 
la- poblacion- de- mexico (accessed 21 Apr 2017).
 25. Patel KV, Peek MK, Wong R, et al. Comorbidity and disability in 
elderly Mexican and Mexican American adults: findings from Mexico 
and the southwestern United States. J Aging Health 2006;18:315–29.
 26. Arriaga EE. Measuring and explaining the change in life 
expectancies. Demography 1984;21:83–96.
 27. Canudas-Romo V, Liu L, Zimmerman L, et al. Potential gains 
in reproductive-aged life expectancy by eliminating maternal 
mortality: a demographic bonus of achieving MDG 5. PLoS One 
2014;9:e86694.
 28. González-González C, Sánchez-García S, Juárez-Cedillo T, et al. 
Health care utilization in the elderly Mexican population: expenditures 
and determinants. BMC Public Health 2011;11:192.
 29. Camarda CG. Mortality smooth: an R package for smoothing poisson 
counts with p-splines. J Stat Softw 2012;50:1–24.
 30. Wilmoth JR, Andreev K, Jdanov D, et al. Methods protocol for 
the human mortality database. . Rostock: University of California, 
Berkeley, and Max Planck Institute for Demographic Research, 
2007:9. 10–11.
 31. Preston S, Heuveline P, Guillot M. Demography: measuring and 
modeling population processes. 2000.
 32. Horiuchi S, Wilmoth JR, Pletcher SD. A decomposition 
method based on a model of continuous change. Demography 
2008;45:785–801.
 33. Aburto JM, van Raalte A. Lifespan dispersion in times of life 
expectancy fluctuation: the case of Central and Eastern Europe. 
Demography. In Press.;2018.
 34. Remund A, Camarda CG, Riffe T. A cause-of-death decomposition of 
young adult excess mortality. Demography 2018;55:1–22.
 35. Zalsman G, Hawton K, Wasserman D, et al. Suicide prevention 
strategies revisited: 10-year systematic review. Lancet Psychiatry 
2016;3:646–59.
 36. Hernández B, Ramírez-Villalobos D, Romero M, et al. Assessing 
quality of medical death certification: concordance between gold 
standard diagnosis and underlying cause of death in selected 
Mexican hospitals. Popul Health Metr 2011;9:38.
 37. Steinberg N. Neither rights nor security: killings, torture, and 
disappearances in mexico's war on drugs: human rights watch. 
2011.
 38. Wright MW. Epistemological ignorances and fighting for the 
disappeared: lessons from Mexico. Antipode 2017;49:249–69.
 39. Gavin JR, Alberti KG, Davidson MB, et al. Report of the expert 
committee on the diagnosis and classification of diabetes mellitus. 
Diabetes Care 2003;26:S5–20.
 40. World Health Organization. Global health observatory data repository 
2018. 2018;364.
 41. World Health Organization. Enfermedades transmisibles y análisis 
de salud/información y análisis de Salud: situación de salud en las 
Américas: indicadores básicos 2013. OPS Washington, 2013.
 42. Beltrán-Sánchez H. Avoidable mortality. International handbook of 
adult mortality: Springer, 2011:491–508.
 43. Nolte E, McKee CM. In amenable mortality--deaths avoidable 
through health care--progress in the US lags that of three European 
countries. Health Aff 2012;31:2114–22.
 44. Holland WW. Commentary: should we not go further 
than descriptions of avoidable mortality? Int J Epidemiol 
2003;32:447–8.
 45. Espinal-Enríquez J, Larralde H. Analysis of México's narco-war 
network (2007-2011). PLoS One 2015;10:e0126503.
 46. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in 
the developing world--a growing challenge. N Engl J Med 
2007;356:213–5.
 47. Aschner P. Obesity in Latin America. In: Metabolic syndrome: a 
comprehensive textbook, 2016:33–9.
 48. Kuri-Morales P, Emberson J, Alegre-Díaz J, et al. The prevalence 
of chronic diseases and major disease risk factors at different ages 
among 150,000 men and women living in Mexico City: cross-
sectional analyses of a prospective study. BMC Public Health 
2009;9:9.
 49. Rivera JA, Barquera S, Campirano F, et al. Epidemiological 
and nutritional transition in Mexico: rapid increase of non-
communicable chronic diseases and obesity. Public Health Nutr 
2002;5:113–22.
 o
n
 2 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022350 on 1 August 2018. Downloaded from 
